Evaluating the Safety and Efficacy of Erythropoietin Therapy for Neonatal Hypoxic-Ischemic Encephalopathy – A Systematic Review and Meta-Analysis (2024) Shayan Marsia, MD

Description

A systematic review and meta-analysis assessing the effectiveness and safety of Erythropoietin (EPO) therapy for treating Neonatal Hypoxic-Ischemic Encephalopathy (HIE). Analyzing seven studies involving 903 infants, the study concludes that the use of EPO did not significantly reduce the risk of death, neurodisability, or cerebral palsy, suggesting current evidence does not support its use for this condition.